Stockscreener 앱 받기
62.53
0.82%
0.50
전일 마감가:
$62.03
열려 있는:
$62.05
하루 거래량:
26,863
Relative Volume:
0.02
시가총액:
$7.58B
수익:
$12.50B
순이익/손실:
$314.00M
주가수익비율:
25.63
EPS:
2.44
순현금흐름:
$421.00M
1주 성능:
-1.00%
1개월 성능:
-7.17%
6개월 성능:
-3.38%
1년 성능:
-12.74%
1일 변동 폭
$62.05
$62.55
1주일 범위
$61.95
$63.96
52주 변동 폭
$60.56
$82.49
헨리 샤인 Stock (HSIC) Company Profile
명칭
Henry Schein Inc
전화
(631) 843-5500
주소
135 DURYEA RD, MELVILLE, NY
HSIC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
62.54 | 7.52B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
779.44 | 96.45B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
320.02 | 61.92B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
CAH
Cardinal Health Inc
|
152.86 | 36.41B | 222.58B | 1.57B | 1.85B | 6.4395 |
|
AHG
Akso Health Group Adr
|
1.63 | 911.67M | 2.22M | -5.63M | -1.68M | -0.24 |
헨리 샤인 Stock (HSIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-07-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-06 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-07-22 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-10 | 업그레이드 | Stifel | Hold → Buy |
| 2022-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-01-31 | 개시 | Morgan Stanley | Underweight |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 재개 | Credit Suisse | Neutral |
| 2021-02-08 | 재개 | Piper Sandler | Overweight |
| 2021-01-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 개시 | Wolfe Research | Underperform |
| 2019-05-15 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-01-17 | 개시 | UBS | Sell |
| 2019-01-03 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2019-01-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 재확인 | Barrington Research | Outperform |
| 2018-10-25 | 다운그레이드 | Edward Jones | Hold → Sell |
| 2018-10-19 | 재개 | Goldman | Neutral |
| 2018-10-04 | 재확인 | Robert W. Baird | Outperform |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-04-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-04-04 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
모두보기
헨리 샤인 주식(HSIC)의 최신 뉴스
Is Henry Schein Inc. stock dividend yield sustainableJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
TAG Expands Tech With Planmeca Partnership - Dentistry Today
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's Infoods®? Ibs Test in the U.S - MarketScreener
Biomerica (BMRA) Partners with Henry Schein to Expand IBS Test R - GuruFocus
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. - The Manila Times
Henry Schein and Biomerica enter into marketing services agreement for Biomerica's inFoods IBS Test in the US - MarketScreener
59.6% of treated patients hit FDA abdominal pain endpoint; Biomerica, Henry Schein to market inFoods® in U.S. (ex NY) - Stock Titan
Will Henry Schein Inc. bounce back from current supportEarnings Recap Summary & Safe Investment Capital Preservation Plans - newser.com
CFRA downgrades Henry Schein (HSIC) to a Sell - The Globe and Mail
Analyzing drawdowns of Henry Schein Inc. with statistical toolsEarnings Risk Report & Fast Gain Swing Alerts - newser.com
1,100 Aspen Dental locations to receive Planmeca Viso, ProMax CBCT and intraoral imaging via The Aspen Group - Stock Titan
Building trade automation scripts for Henry Schein Inc.2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com
Leerink Partners Adjusts Price Target on Henry Schein to $71 From $72, Maintains Market Perform Rating - MarketScreener
Can Henry Schein Inc. stock hit analyst price targetsPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
Understanding Henry Schein Inc.’s price movement2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
Can Henry Schein Inc. recover in the next quarter2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 15.93% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats - MSN
Bank of America Securities Reaffirms Their Buy Rating on Henry Schein (HSIC) - The Globe and Mail
Henry Schein Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Is Henry Schein Inc. stock ready for a breakout2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
What institutional flow reveals about Henry Schein Inc.2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
How sentiment analysis helps forecast Henry Schein Inc.Quarterly Profit Summary & Smart Money Movement Alerts - newser.com
Weiss Ratings Reaffirms Hold (C) Rating for Henry Schein (NASDAQ:HSIC) - MarketBeat
3 Reasons to Avoid HSIC and 1 Stock to Buy Instead - The Globe and Mail
Peering Into Henry Schein Inc's Recent Short Interest - Sahm
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein subsidiary allegedly compromised by Lynx ransomware - SC Media
July 2026 Options Now Available For Henry Schein (HSIC) - Nasdaq
Tick level data insight on Henry Schein Inc. volatilityWeekly Profit Recap & Real-Time Stock Price Movement Reports - newser.com
Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET - ADVFN
How to forecast Henry Schein Inc. trends using time seriesMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Real time breakdown of Henry Schein Inc. stock performanceJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Henry Schein Announces $400 Million Share Repurchase Plan - ADVFN
What Fibonacci levels say about Henry Schein Inc. rebound2025 Price Action Summary & Reliable Price Breakout Alerts - newser.com
Henry Schein Reports Record Second-Quarter 2021 Financial Results From Continuing Operations - ADVFN
Henry Schein (NASDAQ:HSIC) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Henry Schein subsidiary confirms ransomware attack - Cybernews
Is Henry Schein Inc. stock bottoming outTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Using Ichimoku Cloud for Henry Schein Inc. technicalsMarket Risk Analysis & Consistent Profit Trading Strategies - newser.com
헨리 샤인 (HSIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
헨리 샤인 주식 (HSIC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| LASKAWY PHILIP A | Director |
Mar 19 '25 |
Sale |
71.04 |
2,604 |
184,999 |
24,805 |
| Connett Bradford C | CEO, NA Distribution Group |
Mar 19 '25 |
Sale |
71.15 |
4,036 |
287,161 |
62,688 |
1.81%
0.33%
자본화:
|
볼륨(24시간):